131 related articles for article (PubMed ID: 2822337)
1. A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea.
Priestman SG; Priestman TJ; Canney PA
Clin Radiol; 1987 Sep; 38(5):543-4. PubMed ID: 2822337
[TBL] [Abstract][Full Text] [Related]
2. An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Priestman TJ; Priestman SG
Clin Radiol; 1984 Jul; 35(4):265-6. PubMed ID: 6329586
[TBL] [Abstract][Full Text] [Related]
3. Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study.
Crawford SM; Buckman R
Med Oncol Tumor Pharmacother; 1986; 3(1):39-42. PubMed ID: 3010011
[TBL] [Abstract][Full Text] [Related]
4. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Levitt M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
[No Abstract] [Full Text] [Related]
5. Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.
Lewis IH; Campbell DN; Barrowcliffe MP
Br J Anaesth; 1994 Aug; 73(2):244-6. PubMed ID: 7917745
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
Jones SE; Durant JR; Greco FA; Robertone A
Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
[No Abstract] [Full Text] [Related]
7. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
8. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Davis MP
Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients.
Aass N; Håtun DE; Thoresen M; Fosså SD
Radiother Oncol; 1997 Nov; 45(2):125-8. PubMed ID: 9424001
[TBL] [Abstract][Full Text] [Related]
10. Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Ahmedzai S; Carlyle DL; Calder IT; Moran F
Br J Cancer; 1983 Nov; 48(5):657-63. PubMed ID: 6315040
[TBL] [Abstract][Full Text] [Related]
11. Nabilone: an alternative antiemetic for cancer chemotherapy.
Dalzell AM; Bartlett H; Lilleyman JS
Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
Pomeroy M; Fennelly JJ; Towers M
Cancer Chemother Pharmacol; 1986; 17(3):285-8. PubMed ID: 3017596
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.
Bruera E; Belzile M; Neumann C; Harsanyi Z; Babul N; Darke A
J Pain Symptom Manage; 2000 Jun; 19(6):427-35. PubMed ID: 10908823
[TBL] [Abstract][Full Text] [Related]
14. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
15. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
16. Study design for the evaluation of the efficacy and safety of nabilone.
Stark P
Cancer Treat Rev; 1982 Dec; 9 Suppl B():35-7. PubMed ID: 6299553
[No Abstract] [Full Text] [Related]
17. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
Van Eygen M; Dhondt F; Heck E; Ameryckx L; Van Ravensteyn H
Postgrad Med J; 1979; 55 Suppl 1():36-9. PubMed ID: 382153
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
20. The final assessment of a randomized double-blind comparative study of ondansetron vs. metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation.
Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):241-2. PubMed ID: 1834162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
